Novalek Pharma focuses on the development and commercialization of pharmaceutical products to meet the unmet medical needs and improve the lives of patients. Novalek Pharma launched its Oncology division in the year 2011. The division started its domestic operations with 12 anti-cancer drugs and has a rich pipeline of incrementally improved drugs.
We have an established presence in Russia and a high-growth rate in the emerging markets. We are in constant search of partners for collaboration that match our work ethics and commitment to patients across the globe. We look for partnerships as a part of our business strategy. This initiative of ours is supported by a dedicated team for business development managers.